@article{d142486d1e464f00b20b131444a823a3,
title = "Bendamustine (Treanda{\textregistered})-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation",
author = "Bensinger, \{William I.\} and Leona Holmberg and Gooley, \{Theodore A.\} and Till, \{Brian G.\} and Budde, \{Lihua Elizabeth\} and Pagel, \{John M.\} and Frayo, \{Shani L.\} and Roden, \{Jennifer E.\} and Hedin, \{Lacey M.\} and Malcolm Mack and Press, \{Oliver W.\} and Gopal, \{Ajay K.\}",
note = "Graphic][1] Background High dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a standard of care for patients with advanced or treatment refractory multiple myeloma (MM) and non-Hodgkin lymphoma (NHL). Stem cell proliferation and mobilization can be enhanced though the addition of myelosuppressive chemotherapy prior to GCSF administration.",
year = "2013",
month = nov,
day = "15",
language = "American English",
volume = "122",
journal = "Blood",
}